Alec Machiels - 01 Jan 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role: Director
Signature: /s/ David Watson, attorney-in-fact for Alec Machiels
Issuer symbol: APLS
Transactions as of: 01 Jan 2022
Transactions value $: $0
Form type: 4
Filing time: 04 Jan 2022, 20:28:04 UTC
Previous filing: 10 Feb 2022
Next filing: 19 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APLS	Common Stock	Award	$0	+4,230	+0.63%	$0	673,774	01 Jan 2022	Direct	F1
holding	APLS	Common Stock						1,950	01 Jan 2022	See Footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APLS	Stock Option (Right to Buy)	Award	$0	+8,554		$0	8,554	01 Jan 2022	Common Stock	8,554	$47.28	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This represents a restricted stock unit grant made on 1/1/2022 that fully vest on the first anniversary of the date of grant, subject to continued service as a director.
F2	Owned by spouse.
F3	This represents a non-qualified stock option grant made on 1/1/2022 that vests quarterly over 1 year from the date of grant, subject to continued service as a director, and expires seven years from the date of grant.